BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 13, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: After iffy adcom, FDA clears Urogen’s Zusduri mitomycin
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
Bifemelane claimed for cerebrovascular disorders treatment
July 26, 1996
Research supports role of testosterone in pathogenesis of stroke
July 26, 1996
Immunex issued U.S. patent for Lerk-7
July 26, 1996
ERT therapy enhances clinical response to tacrine in Alzheimer's patients
July 26, 1996
CP-122638: Pfizer's potential treatment for non-migraine emesis
July 26, 1996
5-HT3/NK1 antagonist combination effective in emesis treatment and prevention
July 26, 1996
Vanderbilt University describes ligands for 5-HT3 receptors
July 26, 1996
MBP peptide analogues described as multiple sclerosis treatment
July 26, 1996
Yeda claims protein as potential autoimmune disease treatment
July 26, 1996
Chinoin describes new selegiline formulation
July 26, 1996
Previous
1
2
…
2716
2717
2718
2719
2720
2721
2722
2723
2724
…
2748
2749
Next
RSS